Physician profile
Jacques Tran
NPI 1023677366
$3,914.57
in general payments reported to CMS, 2019-2025
23 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,903 · 2023: $722 · 2024: $783 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,200.00 | 2022 | |
| Stryker Corporation | $1,057.03 | 2022-2025 | Augment Injectable, Sonicpin, Prostep Mica |
| Smith+Nephew, INC. | $666.22 | 2022-2025 | Stravix Mesh, Grafix Pl, Collagenase Santyl |
| Eclipse Technology Solutions INC. | $174.21 | 2023-2024 | |
| Organogenesis INC. | $144.99 | 2023-2024 | Puraply, Apligraf |
| Paratek Pharmaceuticals, INC. | $136.97 | 2022-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $67.78 | 2024-2025 | |
| Linvatec Corporation | $61.91 | 2025 | Fracture and Correction Colag 2, 5ms, Biobrace 23mm |
| Averitas Pharma INC. | $61.28 | 2023-2024 | Qutenza |
| Amgen INC. | $42.59 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $41.44 | 2023-2025 | Physio-Stim |
| Kerecis Limited | $34.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Medical Device Business Services, INC. | $30.23 | 2025 | Motoband |
| Next Science LLC | $25.25 | 2023 | Xperience, Blastx, Surgx |
| Solventum Corporation | $24.19 | 2024 | Activ.A.C., Promogran Prisma |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.33 | 2022 | |
| Depuy Synthes Sales INC. | $22.06 | 2022 | |
| Kci USA, INC. | $20.21 | 2023 | Promogran Prisma, Activ.A.C. |
| Integra Lifesciences Corporation | $17.64 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $17.47 | 2023 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.82 | 2023 | Jublia |
| Pacira Pharmaceuticals Incorporated | $15.86 | 2023 | Exparel, Iovera |
| Grt US Holding, INC. | $14.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.